Thymosin Alpha-1

A 28-amino-acid peptide originally isolated from the thymus gland. FDA-approved in over 35 countries for chronic hepatitis B and C, and as an immune adjuvant. Activates dendritic cells, T-cells, and NK cells, strengthening adaptive immune responses. Studied for its potential in cancer immunotherapy, vaccine enhancement, and autoimmune conditions.